Keyphrases
Varicella Zoster Virus
100%
Clinical Significance
100%
Neurological Symptoms
100%
Rash
100%
Cerebrospinal Fluid
100%
Viral PCR
100%
Virus DNA
18%
Cycle Threshold
18%
Nucleoside Analogues
18%
Meningitis
18%
Encephalitis
18%
Viral Burden
18%
Israel
9%
Clinical Manifestations
9%
Laboratory Data
9%
Clinical Data
9%
Demographic Data
9%
Non-associated
9%
Headache
9%
Possible Complications
9%
Acute Disease
9%
Systematic Evaluation
9%
Chronic Illness
9%
Causal Role
9%
Retrospective Cohort
9%
Treatment Evaluation
9%
Common Symptoms
9%
Large Hospital
9%
Prompt Treatment
9%
Monitoring Policy
9%
Treatment Policy
9%
Alternative Diagnosis
9%
PCR Cycles
9%
Symptom Detection
9%
Medicine and Dentistry
Varicella Zoster Virus
100%
Neurologic Disease
100%
Polymerase Chain Reaction
100%
Exanthem
100%
6 Diazo 5 Oxonorleucine
100%
Clinical Significance
100%
Cerebrospinal Fluid
100%
Apoplexy
18%
Virus DNA
18%
Nucleoside Analogue
18%
Symptom
9%
Headache
9%
Acute Disease
9%
Chronic Disease
9%
Pathogen
9%
Meningitis
9%
Virus Meningitis
9%
Virus Encephalitis
9%
Encephalitis
9%
Pharmacology, Toxicology and Pharmaceutical Science
Neurologic Disease
100%
Rash
100%
Varicella Zoster Virus
100%
6 Diazo 5 Oxonorleucine
100%
Virus DNA
18%
Nucleoside Analog
18%
Symptom
9%
Infectious Agent
9%
Headache
9%
Chronic Disease
9%
Encephalitis
9%
Meningitis
9%
Acute Disease
9%
Virus Encephalitis
9%
Virus Meningitis
9%
Neuroscience
Varicella Zoster Virus
100%
DNA Virus
18%
Nucleoside Analog
18%
Meningitis
18%
Encephalitis
18%
Headache
9%